Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
10/23/2003US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management
10/23/2003US20030199546 6-(((2S)-2-(alkoxycabonyl)-4,4-difluoropyrrolidinyl)methyl)-1, 2, 3.4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylate, or acid derivatives, useful for treating migraine, and dural protein extravasation
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199535 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199533 Administering amino, carboxy, alkyl derivatives of barbituric acid to treat diseases of the central nervous system related to the metabotropic glutamate receptor system
10/23/2003US20030199530 New compounds derived from quinazoline
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199508 Compounds and their therapeutic use
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003US20030199500 Tetrahydrofuran derivatives and their use as nk-1 antagonists
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199497 Novel calcium receptor active molecules and method for preparing same
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030199483 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of pathogenic conditions
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199424 of a neuropathic condition, by administering anangiotensin II receptor I (AT1 receptor) antagonists
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198675 Method of providing sustained analgesia with buprenorphine
10/23/2003US20030198666 Side effect reduction; using mixture of insulin and adjuvant
10/23/2003DE19983836C1 Verfahren zur Herstellung von Citalopram, 4-[1-(4- Fluorphenyl)-methanoyl]-benzonitril-Derivate und Verfahren zu deren Herstellung und deren Verwendung A process for the preparation of citalopram, 4- [1- (4-fluorophenyl) -methanoyl] -benzonitrile derivatives and process for their preparation and their use
10/23/2003CA2482937A1 A novel crystal of anhydride of a quinoxalinedione derivative
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482775A1 Fredericamycin derivatives
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482391A1 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2482313A1 Heterocyclic compounds
10/23/2003CA2482312A1 Thienyl compounds
10/23/2003CA2481855A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481313A1 Bicyclic amides
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481272A1 The use of devazepide as analgesic agent
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2481178A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003CA2480858A1 Treatment of gastroparesis
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480671A1 C-jun phosphorylation inhibitors
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/23/2003CA2477692A1 Cyanamides useful as reversible inhibitors of cysteine proteases
10/22/2003EP1355158A1 Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354951A1 Method of examining ability to control nerve cell plasticity
10/22/2003EP1354946A1 Bhlh-pas proteins, genes thereof and utilization of the same
10/22/2003EP1354892A1 Peptides capable of inducing attraction of the axonal growth and their use for treating neurodegenerative diseases
10/22/2003EP1354889A1 Trasncription activation complex and utilization thereof
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354595A1 Composition containing extracts of butyrospermum parkii and its use as medicament or dietary supplement
10/22/2003EP1354585A1 Use of molindone or derivatives thereof for the manufacture of a medicament in the treatment of oppositional defiant disorders and conduct disorders
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354032A2 Gene regulation therapy involving ferritin
10/22/2003EP1354029A2 Foggy
10/22/2003EP1353948A2 Soluble cyclic analogues of the beta amyloide peptide
10/22/2003EP1353944A2 Methods of investigating, diagnosing, and treating amyloidosis
10/22/2003EP1353918A1 Morpholine derivatives as antagonists of orexin receptors
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353914A2 Therapeutic chromone compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353910A2 Lactam compound
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353903A2 Thiol-based naaladase inhibitors
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353896A2 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
10/22/2003EP1353701A2 Methods and compositions for enhanced delivery of bioactive molecules
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
1 ... 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 ... 1833